Published in Spinal Cord on May 31, 2016
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications. Pharmacol Rev (2017) 0.75
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43
A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med (2008) 11.16
Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol (2003) 10.29
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia (2007) 5.67
Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol (2005) 4.96
A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med (2008) 3.80
The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma (2004) 2.48
Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol (2015) 1.71
Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans (2007) 1.63
Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci (2015) 1.53
Burden of illness in Parkinson's disease. Mov Disord (2005) 1.48
Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases. Nat Rev Neurol (2014) 1.44
Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil (2007) 1.35
Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma (2002) 1.28
Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev (2015) 1.13
Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci (2015) 1.10
Synuclein accumulation is associated with cell-specific neuronal death after spinal cord injury. J Comp Neurol (2012) 0.99
Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. Handb Clin Neurol (2012) 0.98
A pilot study on temporal changes in IL-1β and TNF-α serum levels after spinal cord injury: the serum level of TNF-α in acute SCI patients as a possible marker for neurological remission. Spinal Cord (2015) 0.98
Cytokine transport across the injured blood-spinal cord barrier. Curr Pharm Des (2008) 0.93
Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. J Neuroimmunol (2003) 0.93
The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience (2015) 0.89
Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study. PLoS One (2013) 0.89
Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology (2009) 0.85
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease. Front Neurosci (2015) 0.84
Induction of Parkinson disease-related proteins in motor neurons after transient spinal cord ischemia in rabbits. J Cereb Blood Flow Metab (2009) 0.81
Inflammation in acute CNS injury: a focus on the role of substance P. Br J Pharmacol (2015) 0.81
Parkinson's disease and enhanced inflammatory response. Exp Biol Med (Maywood) (2015) 0.79